Inventor · disambiguated record
James Mcclory
Also filed as: MCCLORY JAMES · MCCLORY JAMES BERNARD
3 granted patents·9 pending applications·0 citations·filing 2019–2025
46Inventor score
Files withAMUNIX PHARMACEUTICALS INC5FUSION ANTIBODIES PLC2UNIV TEXAS2VOYAGER THERAPEUTICS INC2BIOARCTIC AB1
Top patents by PatentIndex Score
12 records- 0177US12215156B2HER-2 targeted bispecific compositions and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2023·Granted Feb 4, 2025·0 cites·8 claims
- 0266US12291565B2Tau binding compoundsVOYAGER THERAPEUTICS INC·Filed 2024·Granted May 6, 2025·0 cites·28 claims
- 0362US2023322922A1Her-2 targeted bispecific compositions and methods for making and using the sameAMUNIX PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0459US2025084155A1Anti-hsp70 antibodies and therapeutic uses thereofUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0558US2025382726A1Antibody Library and MethodFUSION ANTIBODIES PLC·Filed 2025·Application pending·0 cites
- 0655US2025282854A1Tau binding compoundsVOYAGER THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0752US2023128075A1Monoclonal antibodies targeting hsp70 and therapeutic uses thereofUNIV TEXAS·Filed 2021·Application pending·0 cites
- 0851US2021054077A1Cd3 antigen binding fragments and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0951US2023121775A1Cd3 antigen binding fragments and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1050US12378696B2Antibody library and methodFUSION ANTIBODIES PLC·Filed 2019·Granted Aug 5, 2025·0 cites·8 claims
- 1147US2025388664A1Bispecific binding moleculeBIOARCTIC AB·Filed 2025·Application pending·0 cites
- 1244US2023312729A1Egfr antigen binding fragments and compositions comprising sameAMUNIX PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Mcclory files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →